A shortlist is not a supplier decision. The best small molecule CDMOs for your project should match the work, the proposed site, and the delivery commitments you need—not just a name in a directory.
Start with a clear project brief. Then compare the evidence behind each proposal, the people who will own delivery, and the full commercial scope. Use this guide to structure the business decision; let your CMC, quality, and legal teams lead technical qualification and contract review.
How do you choose the right small-molecule CDMO?
Choose the best small molecule CDMOs by testing project fit: required services, proposed manufacturing site, quality evidence, available capacity, transfer responsibilities, and complete quote terms. Build a shortlist around those requirements. Advance suppliers only after your technical and quality teams review the evidence for the actual work being proposed.
Which options belong on your shortlist?
A useful list of the best small molecule CDMOs begins with your project, not a league table. Write down what you are buying: active pharmaceutical ingredient (API) development, drug product work, manufacturing, packaging, or a defined combination. If you need a terminology primer, start with what is a CDMO.
Make the request specific. State the development stage, intended dosage form, target markets, expected volumes, existing technical package, and required delivery date. Identify which assumptions are fixed and which still need discussion.
For each candidate, request a scope map showing work done in-house, work sent to another site, and work assigned to a subcontractor. Ask who manages each handoff. Keep API supply, formulation, fill-finish where relevant, and packaging as separate lines until responsibilities are clear.
Do not award credit for services you will not use. A narrow proposal that fits your project deserves a fair comparison with a broad proposal that covers more work.
What evidence separates the best small molecule CDMOs?
Compare three layers: the company, the proposed site, and the committed project plan. Ask the supplier to connect each capability statement to the location, equipment, people, and deliverables offered in your proposal.
Can the proposed site support the actual work?
Request a site-specific technical discussion with your own specialists. Ask the supplier to explain relevant equipment ranges, project limits, analytical work, and the proposed scale-up path. For specialized chemistry or potent compounds, have your technical team define the evidence it needs before accepting a capability claim.
Keep a record of what was demonstrated, what was documented, and what remains outside the agreed scope. Do not substitute a corporate brochure for the technical package your team needs.
What should quality reviewers examine?
Ask your quality team to define its review requirements. These may include inspection history, audit access, investigation records, change control, subcontractor oversight, and the proposed quality agreement. Request records for the site and activities under consideration.
Do not treat a logo, award, or general compliance statement as a completed site assessment. Record the evidence your reviewers accepted and any conditions they place on supplier selection.
Who owns the schedule?
When comparing the best small molecule CDMOs, ask for a dated plan that names both supplier and sponsor responsibilities. Separate estimated timing from written commitments. Identify prerequisites such as material availability, document transfer, method work, and sponsor decisions.
Ask what happens when an assumption changes. Who raises the issue? Who approves the revised plan? Which commitments change, and how will the commercial impact be handled?
What are the tradeoffs between one partner and specialists?
Compare operating models before comparing company size. Use the table below as a discussion guide, not as a ranking of providers.
| Option to evaluate | Question that tests fit | Responsibility to settle |
|---|---|---|
| One partner for several stages | Does the proposal cover every required activity at suitable sites? | Ownership of internal transfers and subcontracted work. |
| API-focused partner | Does the proposed technical approach fit the drug substance work? | Transfer of material, methods, and documents to the next partner. |
| Drug product-focused partner | Does the proposal address the intended dosage form and supplied API? | Incoming material requirements and formulation or manufacturing interfaces. |
| Specialized partner | What project-specific evidence supports the required capability? | Scope boundaries, backup plans, and work outside the specialty. |
Avoid assuming that fewer contracts mean fewer handoffs. Ask where transfers occur under either model. If you choose separate partners, assign a sponsor-side owner to coordinate interfaces and resolve scope gaps.
Which option fits enterprise, mid-market, and specialized buyers?
To identify the best small molecule CDMOs for your organization, match the delivery model to the team you can put behind it. Use company size as context, not as a shortcut for project fit.
Enterprise buyers should test portfolio coordination, reporting, escalation paths, and commitments across the proposed sites. Ask how the supplier will manage competing projects and how changes will reach the sponsor’s decision-makers.
Mid-market buyers should examine the day-to-day workload placed on their own staff. Name who will coordinate transfers, review documents, make decisions, and follow up on actions. Ask for communication arrangements your team can sustain.
Specialized buyers should put technical requirements ahead of service breadth. Have specialists define the qualification questions, acceptable evidence, and project limits. If one partner cannot cover the full scope, document the interfaces before final selection.
How much should you budget?
Compare quotes from the best small molecule CDMOs against the same written scope. Ask for project-specific estimates rather than apply a generic price range to a different molecule, stage, or delivery requirement.
Request separate lines for development, analytical work, technology transfer, manufacturing, testing, stability work, packaging, and storage where those activities belong in your project. Ask suppliers to identify third-party charges and sponsor-provided inputs.
Review exclusions as closely as included services. Clarify cancellation terms, rescheduling, repeat work, failed-batch investigations, material ownership, and payment milestones. Have legal and technical reviewers assess the relevant terms together.
Put every proposal into one comparison sheet. Show the quoted scope, missing items, assumptions, and commitments without assigning invented prices to gaps. Ask each supplier to close those gaps before presenting a final budget recommendation.
How should you compare the best small molecule CDMOs in an RFP?
Use a request for proposal (RFP) to ask each candidate the same project-specific questions. Start with pass-or-fail requirements defined by your technical, quality, procurement, and legal teams. Do not let a strong score elsewhere offset a failed requirement.
After those gates, compare scope clarity, relevant evidence, delivery ownership, schedule commitments, and commercial completeness. Set priorities before reviewing responses so a polished sales presentation does not rewrite the selection criteria.
Use simple ratings such as meets requirement, partly meets requirement, or does not meet requirement. Attach the evidence behind each rating. Separate supplier statements from records your team has examined.
Your final decision paper should identify the proposed site, agreed scope, accepted assumptions, remaining contractual conditions, and reasons for choosing that delivery model. Name the owners of each condition before authorizing the next step.
What should CDMO leaders make clear to buyers?
CDMO leaders seeking consideration among the best small molecule CDMOs should make their public capability information specific. Identify service boundaries, relevant locations, and the path to a technical conversation. Keep public descriptions consistent with what the proposal team can offer.
For commercial teams, CDMO marketing should support that evaluation rather than replace it. Build life sciences marketing content around the questions buyers must resolve: what work fits, where it happens, and what evidence can be shared.
For buyers, the next step is a comparable evidence request—not a longer vendor list. Send the same brief to your shortlist, involve the teams who must qualify the work, and select against the project you intend to run.
About Bob Generale
Bob Generale is President of Percepture. This guide presents an executive approach to comparing supplier scope, evidence, and commercial terms.
